1-4 of 4
Catharine M.L. West
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Developing and Validating a Multivariable Prognostic-Predictive Classifier for Treatment Escalation of Oropharyngeal Squamous Cell Carcinoma: The PREDICTR-OPC Study

Open Access
Hisham Mehanna, Davy Rapozo, Sandra V. von Zeidler, Kevin J. Harrington, Stuart C. Winter, Andrew Hartley, Paul Nankivell, Andrew G. Schache, Philip Sloan, Edward W. Odell, Selvam Thavaraj, Keith D. Hunter, Ketan A. Shah, Gareth J. Thomas, Anna Long, Rasoul Amel-Kashipaz, Rachel M. Brown, Brendan Conn, Gillian L. Hall, Paul Matthews, Justin Weir, Yen Yeo, Miranda Pring, Catharine M.L. West, James McCaul, Pawel Golusinski, Alice Sitch, Rachel Spruce, Nikolaos Batis, Jennifer L. Bryant, Jill M. Brooks, Terence M. Jones, Francesca Buffa, Syed Haider, Max Robinson
Journal: Clinical Cancer Research
Clin Cancer Res (2024) 30 (2): 356–367.
https://doi.org/10.1158/1078-0432.CCR-23-1013
Published: 17 January 2024
View articletitled, Developing and Validating a Multivariable Prognostic-Predictive Classifier for Treatment Escalation of Oropharyngeal Squamous Cell Carcinoma: The PREDICTR-OPC Study
Open the PDF for Developing and Validating a Multivariable Prognostic-Predictive Classifier for Treatment Escalation of Oropharyngeal Squamous Cell Carcinoma: The PREDICTR-OPC Study in another window
Includes: Supplementary data
Journal Articles

Abstract IA-021: Predicting radiotherapy outcomes: Radiogenomics and risk of radiotherapy toxicity

Free
Catharine M.L. West
Journal: Clinical Cancer Research
Clin Cancer Res (2021) 27 (8_Supplement): IA-021.
https://doi.org/10.1158/1557-3265.RADSCI21-IA-021
Published: 15 April 2021
View articletitled, Abstract IA-021: Predicting radiotherapy outcomes: Radiogenomics and risk of radiotherapy toxicity
Journal Articles

A Gene Signature for Selecting Benefit from Hypoxia Modification of Radiotherapy for High-Risk Bladder Cancer Patients

Free
Lingjian Yang, Janet Taylor, Amanda Eustace, Joely J. Irlam, Helen Denley, Peter J. Hoskin, Jan Alsner, Francesca M. Buffa, Adrian L. Harris, Ananya Choudhury, Catharine M.L. West
Journal: Clinical Cancer Research
Clin Cancer Res (2017) 23 (16): 4761–4768.
https://doi.org/10.1158/1078-0432.CCR-17-0038
Published: 14 August 2017
View articletitled, A Gene Signature for Selecting Benefit from Hypoxia Modification of Radiotherapy for High-Risk Bladder Cancer Patients
Open the PDF for A Gene Signature for Selecting Benefit from Hypoxia Modification of Radiotherapy for High-Risk Bladder Cancer Patients in another window
Includes: Supplementary data
Journal Articles

A 26-Gene Hypoxia Signature Predicts Benefit from Hypoxia-Modifying Therapy in Laryngeal Cancer but Not Bladder Cancer

Free
Amanda Eustace, Navin Mani, Paul N. Span, Joely J. Irlam, Janet Taylor, Guy N.J. Betts, Helen Denley, Crispin J. Miller, Jarrod J. Homer, Ana M. Rojas, Peter J. Hoskin, Francesca M. Buffa, Adrian L. Harris, Johannes H.A.M. Kaanders, Catharine M.L. West
Journal: Clinical Cancer Research
Clin Cancer Res (2013) 19 (17): 4879–4888.
https://doi.org/10.1158/1078-0432.CCR-13-0542
Published: 02 September 2013
View articletitled, A 26-Gene Hypoxia Signature Predicts Benefit from Hypoxia-Modifying Therapy in Laryngeal Cancer but Not Bladder Cancer
Open the PDF for A 26-Gene Hypoxia Signature Predicts Benefit from Hypoxia-Modifying Therapy in Laryngeal Cancer but Not Bladder Cancer in another window
Includes: Supplementary data